I only suggest that you watch this on the basis that the market for tech stocks is dead;but the fact remains that this company-MICROGEN-is currently trading on a ridiculous PER of about 3 and has been implementing e-billing services for some quality companies over the last few years.They have stated that they will meet expectations at the interims and their share buy-back programme last year was enhancing for holders.They are cash positive-I think about 6 million-and the only reason for the low sentiment is that they failed to grow at the crazy rate suggested at the height of the boom.The fact is they are growing steadily and e-billing is economic for companies and the market potential remains huge.
The other problem to-day is that most folk are looking for reasons to get out of equities rather than searching for to-morrow's winners.
Anyway,I think this is worth keeping an eye on.

Gone long.

Best chart indicators ive seen in
last 4 days. Check short term KST.

BEEN THROUGH HUNDREDS

About a 1/3rd net cash to market cap.

Forward P/E of 14 cheap for a techie.

Could draw interest from suitors.

Moved up nicely since buying. Reckon this is a hidden gem.

StockMarketWire.com
Microgen confirms that each of its two businesses have made a strong start to 2017 and that directors remain confident the progress at the start of 2017 will continue throughout the year.

The Aptitude Software business has built on the excellent progress it achieved in 2016 with a number of successes in both new and existing markets.

"Aptitude Software has successfully developed its presence in the US healthcare market with two material contracts secured since the start of the year," the company said.

"The opening of this important new market in 2017 complements the continued demand for the Aptitude Revenue Recognition Engine from telcos as they work towards the implementation of IFRS 15 and ASC 606, accounting standards which are effective for annual reporting periods beginning on or after 1 January 2018."

Microgen Financial Systems continued to focus on growing its Trust & Fund Administration business (T&FA) through a combination of organic growth and add-on acquisitions.

"New business progress has continued in 2017 complemented by a number of customers acquired with the add-on acquisitions committing to convert to Microgen 5Series in line with the strategy of the business," it said.

In February 2017 the business announced the acquisition of Primacy Corporation, the fifth add-on acquisition within T&FA since December 2014. The integration of Primacy Corporation continues in line with expectations.